ACC 2018 - Acute Cardiovascular Care (www.escardio.org)

See the poster presentation on suPAR by Dr. Gethin Hodges, Amager-Hvidovre Hospital, Denmark

Visit us at the ViroGates booth no. C1 where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks!

DASEM 2018 - Årsmøde Dansk Selskab for Akutmedicin / Danish Society for Emergency Medicine (www.dasem.dk)

Visit us at the ViroGates booth where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks!

XI Congresso Nazionale SIMEU (Società Italiana di Medicina d’Emergenza-Urgenza)

Our distributor B.S.N. Srl. will be present with a booth and more information about suPARnostic Quick Triage during the coffee breaks!

SEMES 2018 - 30th National Congress Spanish Society of Emergency Medicine (www.semes2018.org)

Visit us at the ViroGates booth where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks!

The Interdisciplinary Congress of Emergency Medicine

Hear the oral presentation "suPAR - New Biomarker in Emergency Practice" by Dr Jesper Eugen-Olsen, Hvidovre Hospital, Denmark on July 5, 16.30 - 17.30 in Botticelli Room.

Our distributor Biomedica will be present with a booth and more information about suPARnostic Quick Triage during the coffee breaks!

EuSEM 2018 - 12'th European Congress on Emergency Medicine (www.eusemcongress.org)
Visit us at the ViroGates booth no.18 where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks!

See the following suPAR presentations at EuSEM:

Free Paper 1: Biomarkers

Sunday, 13.00—14.30, Room Gala, Session F11

• Kevin Bronton (Malmö, Sweden):
“Biomarker risk-stratification of patients with acute dyspnea at the emergency department
using soluble urokinase-type Plasminogen Activating Receptor: A prospective suPAR study
from Sweden” (#FP005)
• Martin Schultz (Herlev, Denmark):
“Use of the prognostic biomarker soluble urokinase plasminogen activator receptor in the
emergency department does not affect mortality, a cluster-randomised clinical trial”
(#FP007)
• Martin Schultz (Herlev, Denmark):
“Early discharge from the emergency department based on soluble urokinase plasminogen
activator receptor levels: a sub-study of the triage iii trial” (#FP008)

e-Poster: Highlight

Monday, 10:45-11:05, Highlight 2, Screen H4, BRK2.1-H4

• Martin Schultz (Herlev, Denmark):
“Availability of soluble urokinase plasminogen activator receptor at triage can provide an
accurate risk stratification in emergency departments: a sub-study of the triage iii trial
(#PH026)

suPAR Hands-On

Tuesday, 12:45-13.15, Exhibition Hall 5

• Visit our “Emergency Room” at the Hands-On session and try doing a suPAR measurement.
Based on the result, decide whether you will discharge or admit your patient

e-Poster: Research

Sunday to Wednesday

• Robert Ivic (Sweden):
“Soluble urokinase plasminogen activator receptor and lactate as prognostic biomarkers in
patients presenting with non-specific complaints in the pre-hospital setting –The prius– trial”
(#15920)

XII International Conference on Nephrology, Renal Replacement Therapy and Kidney Transplantation

Hear the oral presentation "suPAR - A future biomarker" by Dr Jesper Eugen-Olsen, Hvidovre Hospital, Denmark on September 14.

Meet our Sales and Marketing Director Thomas Krarup who will be present with more information about suPARnostic Quick Triage during the coffee breaks!